Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells

Differentiation

Volumn 79, Issue 4-5, 2010, Pages 260-271

  Tan, Genevieve ^a,b   Shim, Winston ^a   Gu, Yacui ^a   Qian, Ling ^a   Ying Chung, Ying ^a   Yun Lim, Sze ^a   Yong, Pearly ^a   Sim, Eugene ^b   Wong, Philip ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cardiomyogenesis; Extracellular matrix; Integrin; Myocardial infarction; Stem cells

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 5; INTEGRIN; RYANODINE RECEPTOR 2; TROPONIN T; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HEART CONTRACTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SYNCYTIUM;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HEMODYNAMICS; HUMANS; INTEGRINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIUM; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 77952882202     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.02.005     Document Type: Article

References (44)

1. An S.S., Kim J., Ahn K., Trepat X., Drake K.J., Kumar S., et al. Cell stiffness, contractile stress and the role of extracellular matrix. Biochem. Biophys. Res. Commun. 2009, 382:697-703.
2. Angele, P., Muller, R., Schumann, D., Englert, C., Zellner, J., Johnstone B., et al., 2008. Characterization of esterified hyaluronan-gelatin polymer composites suitable for chondrogenic differentiation of mesenchymal stem cells. J. Biomed. Mater. Res. A.
3. Beltrami C.A., Finato N., Rocco M., Feruglio G.A., Puricelli C., Cigola E., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994, 89:151-163.
4. Berendsen A.D., Bronckers A.L., Smit T.H., Walboomers X.F., Everts V. Collagen type V enhances matrix contraction by human periodontal ligament fibroblasts seeded in three-dimensional collagen gels. Matrix Biol. 2006, 25:515-522.
5. Berry, M.F., Engler, A.J., Woo, Y.J., Pirolli, T.J., Bish, L.T., Jayasankar, V., et al., 2006. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance, Am. J. Physiol. Heart Circ. Physiol.
6. Breuls R.G., Klumpers D.D., Everts V., Smit T.H. Collagen type V modulates fibroblast behavior dependent on substrate stiffness. Biochem. Biophys. Res. Commun. 2009, 380:425-429.
7. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
8. Docheva D., Popov C., Mutschler W., Schieker M. Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J. Cell Mol. Med. 2007, 11:21-38.
9. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
10. Frantz S., Vallabhapurapu D., Tillmanns J., Brousos N., Wagner H., Henig K., et al. Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. Eur. J. Heart Fail 2008, 10:119-124.
11. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
12. Grinnemo K.H., Mansson-Broberg A., Leblanc K., Corbascio M., Wardell E., Siddiqui A.J., et al. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann. Med. 2006, 38:144-153.
13. Gronthos S., Simmons P.J., Graves S.E., Robey P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001, 28:174-181.
14. Hahn J.Y., Cho H.J., Kang H.J., Kim T.S., Kim M.H., Chung J.H., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J. Am. Coll. Cardiol. 2008, 51:933-943.
15. Katritsis D.G., Sotiropoulou P.A., Karvouni E., Karabinos I., Korovesis S., Perez S.A., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc. Interv. 2005, 65:321-329.
16. Kraehenbuehl T.P., Zammaretti P., Van der Vlies A.J., Schoenmakers R.G., Lutolf M.P., Jaconi M.E., et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008, 29:2757-2766.
17. Kundu, A.K., Khatiwala, C.B., and Putnam, A.J., 2008. Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(lactide-co-glycolide) substrates. Tissue Eng. Part A.
18. Li X., Yu X., Lin Q., Deng C., Shan Z., Yang M., et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell Cardiol. 2007, 42:295-303.
19. Liang Q., Wiese R.J., Bueno O.F., Dai Y.S., Markham B.E., Molkentin J.D. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol. Cell Biol. 2001, 21:7460-7469.
20. Liu J., He X., Corbett S.A., Lowry S.F., Graham A.M., Fassler R., et al. Integrins are required for the differentiation of visceral endoderm. J. Cell Sci. 2009, 122:233-242.
21. Lunde K., Solheim S., Forfang K., Arnesen H., Brinch L., Bjornerheim R., et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J. Am. Coll. Cardiol. 2008, 51:674-676.
22. Martin-Rendon, E., Sweeney, D., Lu, F., Girdlestone, J., Navarrete, C., Watt, S.M., 2008. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang.
23. Meluzin, J., Janousek, S., Mayer, J., Groch, L., Hornacek, I., Hlinomaz, O., et al., 2007. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int. J. Cardiol.
24. Molina E.J., Palma J., Gupta D., Torres D., Gaughan J.P., Houser S., et al. Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. J. Thorac. Cardiovasc. Surg. 2008, 135:292-299. 299 e291.
25. Murasawa Y., Hayashi T., Wang P.C. The role of type V collagen fibril as an ECM that induces the motility of glomerular endothelial cells. Exp. Cell Res. 2008, 314:3638-3653.
26. Norol F., Bonnet N., Peinnequin A., Chretien F., Legrand R., Isnard R., et al. GFP-transduced CD34+ and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct. Exp. Hematol. 2007, 35:653-661.
27. Olivares E.L., Ribeiro V.P., Werneck de Castro J.P., Ribeiro K.C., Mattos E.C., Goldenberg R.C., et al. Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H464-H470.
28. Pacher P., Mabley J.G., Liaudet L., Evgenov O.V., Marton A., Hasko G., et al. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2132-H2137.
29. Penicka M., Horak J., Kobylka P., Pytlik R., Kozak T., Belohlavek O., et al. Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. J. Am. Coll. Cardiol. 2007, 49:2373-2374.
30. Ross R.S., Borg T.K. Integrins and the myocardium. Circ. Res. 2001, 88:1112-1119.
31. Ruggiero F., Champliaud M.F., Garrone R., Aumailley M. Interactions between cells and collagen V molecules or single chains involve distinct mechanisms. Exp. Cell Res. 1994, 210:215-223.
32. Ruggiero F., Comte J., Cabanas C., Garrone R. Structural requirements for alpha 1 beta 1 and alpha 2 beta 1 integrin mediated cell adhesion to collagen V. J Cell Sci 1996, 109(Pt 7):1865-1874.
33. Schierling, W., Kunz-Schughart, L.A., Muders, F., Riegger, G.A., and Griese, D.P., 2008. Fates of genetically engineered haematopoietic and mesenchymal stem cell grafts in normal and injured rat hearts, J. Tissue Eng. Regen. Med.
34. Schneller M., Vuori K., Ruoslahti E. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. Embo. J. 1997, 16:5600-5607.
35. Shim W.S., Jiang S., Wong P., Tan J., Chua Y.L., Tan Y.S., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun. 2004, 324:481-488.
36. Shimomura T., Jia F., Niyibizi C., Woo S.L. Antisense oligonucleotides reduce synthesis of procollagen alpha1 (V) chain in human patellar tendon fibroblasts: potential application in healing ligaments and tendons. Connect Tissue Res. 2003, 44:167-172.
37. Sinanan, A.C., Machell, J.R., Wynne-Hughes, G.T., Hunt, N.P., Lewis, M.P., 2008. alphavbeta3 and alphavbeta5 integrins and their role in muscle precursor cell adhesion. Biol. Cell.
38. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
39. Takeda Y., Mori T., Imabayashi H., Kiyono T., Gojo S., Miyoshi S., et al. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?. J. Gene Med. 2004, 6:833-845.
40. Wang T., Xu Z., Jiang W., Ma A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int. J. Cardiol. 2006, 109:74-81.
41. Wenstrup, R.J., Florer, J.B., Brunskill, E.W., Bell, S.M., Chervoneva, I., Birk, D.E., 2004. Type V collagen controls the initiation of collagen fibril assembly. J. Biol. Chem.
42. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
43. Xaymardan M., Tang L., Zagreda L., Pallante B., Zheng J., Chazen J.L., et al. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes. Circ. Res. 2004, 94:E39-E45.
44. Xu W., Zhang X., Qian H., Zhu W., Sun X., Hu J., et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp. Biol. Med. (Maywood) 2004, 229:623-631.